Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
09/18/1997 | CA2248158A1 Targeted site specific drug delivery compositions and method of use |
09/18/1997 | CA2248076A1 Polymeric delivery of radionuclides and radiopharmaceuticals |
09/18/1997 | CA2248013A1 Methods of treating or preventing interstitial cystitis |
09/18/1997 | CA2247822A1 Methods of treating or preventing interstitial cystitis |
09/18/1997 | CA2247804A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
09/18/1997 | CA2247432A1 Targeting macromolecular prodrugs to t lymphocytes |
09/18/1997 | CA2246768A1 Uses of gdnf and gdnf receptor |
09/18/1997 | CA2225913A1 Persephin and related growth factors |
09/18/1997 | CA2220768A1 Smoking cessation treatments using naltrexone and related compounds |
09/18/1997 | CA2200165A1 Pyridine derivative, anti-ulcer drug, and antibacterial drug |
09/17/1997 | EP0795560A1 Keratan sulfate oligosaccharide fraction and drug containing the same |
09/17/1997 | EP0795556A1 4-Substituted pyrrolopyrimidine compounds as tyrosin kinase inhibitors |
09/17/1997 | EP0795553A1 Production of isoflavone enriched fractions from soy protein extracts |
09/17/1997 | EP0795549A1 Bis-aryloxy(amino)-triazinyl-oxy(amino)aryl derivatives, their preparation and their use as antiviral agents |
09/17/1997 | EP0795547A1 (Aminoalkyl- and acylaminoalkyl-oxy)benzyloxyquinolines, process for their preparation and use as Bradykinin receptor antagonists |
09/17/1997 | EP0795334A2 Prodrugs for the treatment tumors and inflammatory diseases |
09/17/1997 | EP0795330A1 Medicament for the treatment of insomnia |
09/17/1997 | EP0795329A1 Parenterally injectable piroxicam solutions |
09/17/1997 | EP0795328A1 Use of naphthalene derivatives in treating lung carcinoma |
09/17/1997 | EP0795327A1 Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin |
09/17/1997 | EP0795326A1 Ocular tension depressant |
09/17/1997 | EP0795025A1 Enantioselective preparation of pharmaceutically active sulfoxides by bioreduction |
09/17/1997 | EP0795024A1 Enantioselective preparation of pharmaceutically active sulfoxides by biooxidation |
09/17/1997 | EP0795015A1 Plasmids suitable for il-2 expression |
09/17/1997 | EP0795011A1 Method and compositions for reducing cholesterol absorption |
09/17/1997 | EP0794963A2 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells |
09/17/1997 | EP0794956A1 Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
09/17/1997 | EP0794955A1 Hindered n-oxide esters of rapamycin and their use as medicaments |
09/17/1997 | EP0794954A1 Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same |
09/17/1997 | EP0794953A1 Quinazoline derivatives |
09/17/1997 | EP0794951A1 Processes and intermediates for preparing cis(+)3- 4,-6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline |
09/17/1997 | EP0794949A1 Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs |
09/17/1997 | EP0794944A1 Perhydroisoindole derivatives as antagonists of substance p |
09/17/1997 | EP0794942A1 Substituted biphenyl compounds for the treatment of inflammation |
09/17/1997 | EP0794939A1 Novel multiple-substituent dtpa derivatives and metal complexes thereof, pharmaceutical compositions containing such complexes, their use in diagnosis and therapy, methods of preparing the complexing agents and complexes and methods of preparing the pharmaceutical compositions |
09/17/1997 | EP0794938A1 Novel substituted dtpa derivatives, their metal complexes, pharmaceutical compositions containing these complexes and their use in diagnosis and therapy |
09/17/1997 | EP0794799A2 Use of metal complexes as liver and gall bladder radiodiagnosis agents in computer tomography |
09/17/1997 | EP0794797A1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
09/17/1997 | EP0794794A1 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
09/17/1997 | EP0794793A1 Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors |
09/17/1997 | EP0794789A1 Inhibitors of prenyl transferases |
09/17/1997 | EP0794788A1 Hepatic-directed compounds and reagents for preparation thereof |
09/17/1997 | EP0794787A1 Compositions for the treatment of parasitic and fungal infections |
09/17/1997 | EP0794786A1 The use of inositoltrisphosphate for the preparing of medicaments |
09/17/1997 | EP0794785A1 Growth factor expression in human pregnant cervix |
09/17/1997 | EP0794784A1 Combination chemotherapy of suramin and a vinca-alkaloid or estramustine |
09/17/1997 | EP0794783A1 Cyclodextrins as suspending agents for pharmaceutical suspensions |
09/17/1997 | EP0794782A1 Cobalt schiff base compounds |
09/17/1997 | EP0794781A1 Drugs to prevent recurrent herpes virus infections |
09/17/1997 | EP0794780A1 Quinazolinone-containing pharmaceutical compositions and methods for the use thereof |
09/17/1997 | EP0794778A1 Resin particle, medical material and pharmaceutical preparation containing said resin particle |
09/17/1997 | EP0794777A1 Lubeluzole intravenous solutions |
09/17/1997 | EP0794776A2 Use of rifabutin and a combination of rifabutin and atovaquone in the treatment of pneumocystis carinii infections |
09/17/1997 | EP0794775A1 Green porphyrins as immunomodulators |
09/17/1997 | EP0794774A1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds |
09/17/1997 | EP0794773A1 1,4,4-(trisubstituted)cyclohexane monomers and related compounds |
09/17/1997 | EP0794772A1 A method for enhancing outflow of aqueous humor in treatment of glaucoma |
09/17/1997 | EP0794771A1 Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis |
09/17/1997 | EP0794770A1 Transdermal preparation containing a loratidine metabolite with antihistaminic activity |
09/17/1997 | EP0794768A1 A ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating |
09/17/1997 | EP0794767A1 Stable budesonide solutions, method of preparing them and use of these solutions as enema preparations and pharmaceutical foams |
09/17/1997 | EP0755675B1 Dermatological and/or pharmaceutical composition, process of preparation and utilization |
09/17/1997 | EP0721328A4 Camptothecin formulations |
09/17/1997 | EP0711164B1 4-aza-pregnane 5-alpha-reductase isozyme 1 inhibitors |
09/17/1997 | EP0707475B1 Extended release, film-coated tablet of astemizole and pseudoephedrine |
09/17/1997 | EP0703732B1 Food and/or pharmaceutical composition having a low polyamine content |
09/17/1997 | EP0698022B1 1,4-benzoxazine derivatives as potassium channel openers |
09/17/1997 | EP0696283B1 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
09/17/1997 | EP0683773B1 Hypolipidaemic condensed 1,4-thiazepines |
09/17/1997 | EP0655057B1 Cyanoguanidines as potassium channel blockers |
09/17/1997 | EP0647235B1 Process for steroidal peracyl glycosides |
09/17/1997 | EP0639275B1 NOVEL GABAa RECEPTOR SUBTYPES AND METHODS FOR SCREENING DRUG COMPOUNDS USING IMIDAZOQUINOXALINES AND PYRROLOPYRIMIDINES TO BIND TO GABAa RECEPTOR SUBTYPES |
09/17/1997 | EP0635009B1 Novel derivatives of 2,3-dihydro-2,2,4,6,7-pentaalkyl-5-benzofuranols |
09/17/1997 | EP0615435B1 Skin care composition |
09/17/1997 | EP0610357B1 Transdermal therapeutic systems containing crystallization inhibitors |
09/17/1997 | EP0607128B1 Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals |
09/17/1997 | EP0525123B1 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |
09/17/1997 | CN1159809A Process for making quinolonyl lactam antimicrobials and novel intermediate compounds |
09/17/1997 | CN1159808A Spiro-azabicyclic compounds useful in therapy |
09/17/1997 | CN1159807A New heterocyclic substituted imidazoloquinoxalinones their preparation and their use |
09/17/1997 | CN1159806A Imidazopyridine-pyrrolidone and imidazopyridine-oxaolidone |
09/17/1997 | CN1159805A Nvel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
09/17/1997 | CN1159804A Dihydrobenzofuranes |
09/17/1997 | CN1159803A Substituted Arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria |
09/17/1997 | CN1159801A Colchicine derivatives and the therapeutical use thereof |
09/17/1997 | CN1159797A Aryloxy and arylthiopropanolamine derivative suseful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
09/17/1997 | CN1159755A Use of 2,4-diamino pyrimidine 3-oxide or a salt thereof for treating collagen maturation and structuring disorders |
09/17/1997 | CN1159754A Improved pharmaceutical formulations containing ibuprofen and codeine |
09/17/1997 | CN1159753A Anti-acne cosmetic compositions |
09/17/1997 | CN1159752A Denture adhesive |
09/17/1997 | CN1159448A Benzothiophene compounds, intermediates, compositions, and methods |
09/17/1997 | CN1159444A Sulfuryl amino substituted benzoyl guanidine, preparation process and applications as medicine or diagnostic agent and the medicine containing same |
09/17/1997 | CN1159443A Novel gem-difluoro derivatives of phenylacetemide- and phenylacetic acid and their pharmaceutical uses |
09/17/1997 | CN1159325A Co-therapy for Parkinson's syndrome |
09/17/1997 | CN1159324A Active oxygen, free radical scavenger |
09/17/1997 | CN1159323A Medicinal compositionf or preventing and curing xerophthalmia and disease led themby, method and apparatus |
09/17/1997 | CN1159322A Use of procysteine as depigmenting agent |
09/17/1997 | CN1035878C Indolopyrrolocarbazole derivatives |
09/17/1997 | CN1035876C Tetrahydrothiophene derivatives and medicine composition thereof |
09/17/1997 | CN1035859C Metronidazoli hydrochloride intramuscular injection |